Heterogeneous delivery across the blood-brain barrier limits the efficacy of an EGFR-targeting antibody drug conjugate in glioblastomaBianca M. Marin, Jann N. Sarkaria, Surabhi Talele et al.|Neuro-Oncology|2021Cited by 81
Quantitative Phosphoproteomics Reveals Wee1 Kinase as a Therapeutic Target in a Model of Proneural GlioblastomaRebecca S. Lescarbeau, Forest M. White, Katrina K. Bakken et al.|Molecular Cancer Therapeutics|2016Cited by 38
Quantitative Analysis of Tyrosine Phosphorylation from FFPE Tissues Reveals Patient-Specific Signaling NetworksIshwar N. Kohale, Forest M. White, Danielle M. Burgenske et al.|Cancer Research|2021Cited by 37
Quantitative Phosphoproteomics Reveals Wee1 Kinase as a Therapeutic Target in a Model of Proneural GlioblastomaRebecca S. Lescarbeau, Forest M. White, Katrina K. Bakken et al.|Molecular Cancer Therapeutics|2016Cited by 5
WSD-0922, a novel brain-penetrant inhibitor of epidermal growth factor receptor, promotes survival in glioblastoma mouse modelsJason E. Conage‐Pough, Forest M. White, Sylwia A. Stopka et al.|Neuro-Oncology Advances|2023Cited by 5